Shanghai ScreeNingBio Co.,Ltd.

Cellax Biotechnology Co., Ltd. is a wholly-owned subsidiary of ScreeNingBio Technology Co., Ltd., responsible for the commercial operations of ScreeNingBio's products and technical services. Founded in 2020, the company ScreeNingBio operates dual centers in Shanghai, China and San Diego, USA. As a specialized biopharmaceutical CRO (Contract Research Organization), we are dedicated to empowering the early stages of drug discovery. Our core services encompass a broad spectrum, including functional cell line development, drug screening (including high-throughput screening), selectivity and safety evaluation, in vitro assay development and validation, and mechanism of action studies. Through continuous independent innovation, ScreeNingBio has successfully developed a comprehensive portfolio of functional cell lines and drug screening assays targeting novel therapeutic targets (such as GPCRs and ion channels). We are committed to building an advanced screening platform characterized by rich assay models, rigorous protocols, and reliable data, ultimately delivering high-quality and efficient technical services to pharmaceutical companies worldwide.